Nothing is perfect. That can certainly be said for the comprehensive front-page article the New York Times ran this Saturday, April 5, on the high cost of new type 1 diabetes tools. While the story was one of the best we’ve seen in describing the challenges of insulin dependence and the huge cost barriers that exist for patients in our convoluted American healthcare system, some felt that it actually disses innovation in diabetes tools –…Read more »
Welcome back to another Saturday edition of our weekly advice column Ask D’Mine.
Note from your host Wil Dubois, a veteran type 1, diabetes author and community educator in New Mexico:
It’s been a rough week for me, People. It started with one of my patients trying to commit suicide in the lobby of the clinic and pretty much went downhill from there. Why did he want to kill himself? Because his insurance refused to…